Taiwanese-Danish firm BluSense Diagnostics has developed a device to diagnose COVID-19 with 90 percent certainty within 12 minutes using one drop of blood, and the EU next month could license it for use and it could be available in Taiwan by June.
Company president Filippo Bosco and executive vice president Jessie Sun (孫偉芸) yesterday demonstrated the machine at a news conference.
The device, no larger than an electronic blood pressure monitor, can detect immunoglobulins M and G, which are antibodies produced in the body in the early and mid-late stage of COVID-19 infection, Sun said.
Photo: Yang Mien-chieh, Taipei Times
As it is capable of producing results within 12 minutes, the machine could help detect whether patients are infected during the recovery period, screen local cluster infections, detect asymptomatic patients and screen those traveling abroad, she said.
It could also be used to verify whether patients should be cleared to leave the hospital, she added.
The machine last week underwent preliminary clinical tests at the Hvidovre Hospital near Copenhagen, Bosco said.
It has been able to identify whether the 15 subjects used in testing were positive or negative for the SARS-CoV-2, the virus that causes COVID-19, he said.
The company next week is looking to hold a larger-scale clinical trial — about 200 subjects — in Italy, Bosco said, adding that negotiations for conducting clinical trials in Taiwan are ongoing.
BluSense has previously developed diagnostic platforms for the Zika and dengue viruses, and the new platform had simply replaced the Zika and dengue virus antigen with a COVID-19 antigen, Sun said.
BluSense was established in 2014, with its equipment manufacturing and hardware development centers in Taoyuan’s Gueishan District (龜山), while its biochemistry research and development branch is in Copenhagen.
It received a US Agency for International Development grant in 2016 for developing ViroTrack, a rapid point of care diagnostics system using Blu-ray-based optical detection.
A fugitive in a suspected cosmetic surgery fraud case today returned to Taiwan from Canada, after being wanted for six years. Internet celebrity Su Chen-tuan (蘇陳端), known as Lady Nai Nai (貴婦奈奈), and her former boyfriend, plastic surgeon Paul Huang (黃博健), allegedly defrauded clients and friends of about NT$1 billion (US$30.66 million). Su was put on a wanted list in 2019 when she lived in Toronto, Canada, after failing to respond to subpoenas and arrest warrants from the Taipei District Prosecutors’ Office. Su arrived at Taiwan Taoyuan International Airport at 5am today on an EVA Air flight accompanied by a
COVID-19 infections have climbed for three consecutive weeks and are likely to reach another peak between next month and June, the Centers for Disease Control (CDC) said yesterday. Weekly hospital visits for the disease increased by 19 percent from the previous week, CDC Epidemic Intelligence Center Director Guo Hung-wei (郭宏偉) said. From Tuesday last week to yesterday, 21 cases of severe COVID-19 and seven deaths were confirmed, and from Sept. 1 last year to yesterday, there were 600 cases and 129 deaths, he said. From Oct. 1 last year to yesterday, 95.9 percent of the severe cases and 96.7 percent of the deaths
An essay competition jointly organized by a local writing society and a publisher affiliated with the Chinese Communist Party (CCP) might have contravened the Act Governing Relations Between the People of the Taiwan Area and the Mainland Area (臺灣地區與大陸地區人民關係條例), the Mainland Affairs Council (MAC) said on Thursday. “In this case, the partner organization is clearly an agency under the CCP’s Fujian Provincial Committee,” MAC Deputy Minister and spokesperson Liang Wen-chieh (梁文傑) said at a news briefing in Taipei. “It also involves bringing Taiwanese students to China with all-expenses-paid arrangements to attend award ceremonies and camps,” Liang said. Those two “characteristics” are typically sufficient
Restarting the No. 2 reactor at the Ma-anshan Nuclear Power Plant would take up to 18 months, Minister of Economic Affairs J.W. Kuo (郭智輝) said today. Kuo was answering questions during a meeting of the Legislative Yuan’s Economics Committee, where legislators are considering amendments to the Renewable Energy Development Act (再生能源發展條) amid concerns about the consequences of the Pingtung County reactor’s decommissioning scheduled for May 17. Its decommissioning is to mark the end of Taiwan’s nuclear power production. However, Chinese Nationalist Party (KMT) lawmakers have proposed an amendment to the Nuclear Reactor Facilities Regulation Act (核子反應器設施管制法) that would extend the life of existing